BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 31, 2009
View Archived Issues
RheothRx now in development for pain in sickle cell crisis
Read More
Vanguard Medica antimigraine drug in phase II
Read More
Eisai Alzheimer's drug in advanced development
Read More
Transcend's procysteine progresses in the clinic
Read More
GlaxoSmithKline presents second quarter 2009 results
Read More
Delcath Systems updates clinical progress with melphalan and its PHP drug delivery system
Read More
Mologen to include additional dosing group in phase Ib/IIa study of MGN-1703
Read More
Immunomedics and Alexis sign partnership agreement for vaccines against cancer and AIDS
Read More
Can-Fite licenses allosteric modulators from Leiden University and the NIH
Read More
Avi and Action Duchenne collaborate for Duchenne muscular dystrophy treatment
Read More
SUVN-502 shown to be safe and well tolerated in phase I trial in healthy subjects
Read More
CAD-106 is safe and immunogenic in first-in-man trial in AD patients
Read More
S1P1 receptor agonists claimed by Arena for inflammatory and autoimmune diseases
Read More
Genentech claims MEK kinase inhibitors for cancer treatment
Read More
Novel mu-opioid receptor ligands discovered at NeuroSearch
Read More
Bayer Schering Pharma claims PPARalpha ligands for the treatment of dyslipidemia
Read More
GlaxoSmithKline discovers CGRP antagonists for the treatment of migraine
Read More
Cell Therapeutics initiates marketing approval process for pixantrone in Europe
Read More
Evotec receives milestone payment from collaboration with Boehringer Ingelheim
Read More
European Commission approves broader label for Avastin in breast cancer
Read More
Foresight initiates FST-100 trial in viral conjunctivitis
Read More
NHLBI stops clinical trial of sildenafil for PH in sickle cell disease
Read More
MVI and Crucell form partenership to accelerate development of malaria vaccine
Read More
AstraZeneca to initiate phase IIb study of CytoFab for severe sepsis
Read More
Cardium presents update on phase IIb MATRIX study of Excellarate in diabetic ulcers
Read More
Merck & Co. pays Cardiome milestone after filing for European approval for vernakalant
Read More
Etravirine treatment shows safety and efficacy in HIV patients; pooled phase III data disclosed
Read More
VIR-201 vaccine partially suppresses HIV replication in phase I/IIa clinical trial
Read More
PET tracer BAY-94-9172 shown promise as diagnostic agent for AD in phase II trials
Read More
GlaxoSmithKline and Genmab report top-line results for ofatumumab in RA
Read More